Previous studies have demonstrated that DNA‐demethylating agents activate the innate immune system via the MDA5 (melanoma differentiation‐associated protein 5) /MAVS (mitochondrial antiviral‐signaling) RNA recognition pathway in tumor cells (Chiappinelli et al, 2015; Roulois et al, 2015). This evidence concerns the gene MAVS and neoplasm.